|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3570885 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18714635.2 |
| Date of filing the European patent application | 2018-01-16 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-18 |
| (46) | Date of publication of the claims translation | 2024-12-27 |
| (86) | Number | PCT/US2018/013918 |
| Date | 2018-01-16 |
| (87) | Number | WO 2018/136440 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 201762447332 P | 2017-01-17 | US |
| (72) |
CHENG, Yuan , US
NETIROJJANAKUL, Chawita , US
HOLDER, Jerry Ryan , US
WU, Bin , US
FALSEY, James R. , US
HERBERICH, Bradley J. , US
SHAM, Kelvin , US
MIRANDA, Leslie P. , US
LU, Shu-Chen , US
VENIANT-ELLISON, Murielle M. , US
STANISLAUS, Shanaka , US
YIE, Junming , US
XU, Jing , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive
Thousand Oaks, California 91320,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Metabolinių sutrikimų gydymo ar palengvinimo būdas, naudojant GLP-1 receptorių agonistus, konjuguotus su skrandžio inhibitorinio peptido receptorių (GIPR) antagonistais |
| METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO ANTAGONISTS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) |
| Payment date | Validity (years) | Amount | |
| 2025-12-17 | 9 | 208.00 EUR |
| 2027-01-16 |